If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.70    -0.27 (-13.71%)
Bid:
1.70
Ask:
2.00
Spread: 0.30 (17.647%)
Market Cap: £5.96m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

23 Dec 2009 15:55

RNS Number : 6704E
Proteome Sciences PLC
23 December 2009
 



Proteome Sciences plc 

("Proteome Sciences" or "the Company")

Resignation of Director 

and 

Appointment of Chief Operating Officer

23rd December 2009: The Board of Proteome Sciences announces that Dr. Peter Schulz-Knappe will be leaving Proteome Sciences R&D GmbH & Co. KG on 31st December 2009 in order to be based more closely to his family, at which point he will resign as a director from the Company. The directors would like to thank Dr. Schulz-Knappe for his considerable contribution to the Company's progress and wish him every success in the future.

The Company is pleased to announce that Dr. Ian Pike has been appointed Chief Operating Officer of the Company and its subsidiaries and that Dr. Hans-Dieter Zucht has been appointed as Chief Technical Officer of Proteome Sciences R&D GmbH Co. KG in Frankfurt. Neither of these are appointments to the board of Proteome Sciences.

Ends

For further information please contact: 

Proteome Sciences plc

www.proteomics.com

Tel: +44 (0)1932 865065

Christopher Pearce, Chief Executive

James Malthouse, Finance Director 

Dr. Ian Pike, Chief Operating Officer

Email: christopher.pearce@proteomics.com

Email: james.malthouse@proteomics.com

Email: ian.pike@proteomics.com

Public Relations

IKON Associates 

Adrian Shaw

Tel: +44 (0)1483 271291

Mobile: +44 (0)797 9900733

Email: adrian@ikonassociates.com

Redleaf Communications Ltd. 

Samantha Robbins / Anna Dunkin 

Tel: +44 (0)20 7566 6700

Email: proteome@redleafpr.com

Nominated Adviser

Noble & Company Ltd.

John Llewellyn-Lloyd

Tel: +44 (0)20 7763 2200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEXLFLKLBEFBZ
Date   Source Headline
30th Jun 20104:27 pmRNSResult of AGM,Loan Conversion,Total Voting Rights
28th Jun 20105:59 pmRNSCOMPLETION OF PLACING AND OVERSUBSCRIBED OPEN OFFE
18th Jun 20107:00 amRNSUpdate on warranty claim
17th Jun 20109:00 amRNSReport and Accounts
11th Jun 20107:00 amRNSPublication of Circular
8th Jun 201011:21 amRNSHolding(s) in Company
7th Jun 20104:40 pmRNSSecond Price Monitoring Extn
7th Jun 20104:35 pmRNSPrice Monitoring Extension
7th Jun 20104:22 pmRNSPreliminary Results
7th Jun 20104:17 pmRNSPlacing, Open Offer & Loan Conversion
2nd Jun 20107:00 amRNSReimbursement of lung cancer test in USA
26th Apr 201011:55 amRNSBlocklisting Interim Review
9th Apr 20107:00 amRNSLicense Agreement
11th Feb 20108:18 amRNSAlliance with Parexel
9th Feb 20107:00 amRNSChange of Adviser
1st Feb 20102:01 pmRNSHolding(s) in Company
23rd Dec 20093:55 pmRNSDirectorate Change
16th Nov 20091:39 pmRNSHolding(s) in Company
28th Oct 20097:00 amRNSRe Contract
26th Oct 20097:00 amRNSBlock Admission
23rd Oct 20094:40 pmRNSSecond Price Monitoring Extn
23rd Oct 20094:35 pmRNSPrice Monitoring Extension
30th Sep 20097:00 amRNSHalf Yearly Report
25th Sep 20094:40 pmRNSSecond Price Monitoring Extn
25th Sep 20094:35 pmRNSPrice Monitoring Extension
10th Sep 20094:40 pmRNSSecond Price Monitoring Extn
10th Sep 20094:35 pmRNSPrice Monitoring Extension
9th Sep 20094:40 pmRNSSecond Price Monitoring Extn
9th Sep 20094:35 pmRNSPrice Monitoring Extension
28th Aug 20094:40 pmRNSSecond Price Monitoring Extn
28th Aug 20094:35 pmRNSPrice Monitoring Extension
16th Jul 20093:39 pmRNSHolding(s) in Company
14th Jul 200910:26 amRNSResult of AGM
6th Jul 20097:00 amRNSLicensing Agreement
30th Jun 20094:40 pmRNSSecond Price Monitoring Extn
30th Jun 20094:35 pmRNSPrice Monitoring Extension
22nd Jun 20098:00 amRNSPosting of Report & Accounts
18th Jun 20097:00 amRNSPreliminary Results
27th May 20097:00 amRNSLicense Agreement in Brain Damage
5th May 20092:40 pmRNSHolding(s) in Company
28th Apr 20092:20 pmRNSBlocklisting Interim Review
30th Mar 20097:00 amRNSChange of Adviser
23rd Mar 200910:30 amRNSHolding(s) in Company
18th Mar 20094:55 pmRNSHolding(s) in Company
9th Mar 20097:00 amPRNISO 9001: 2008 Certification
26th Feb 200911:09 amPRNCorrection : Holding(s) in Company
26th Feb 20099:00 amPRNHolding(s) in Company
15th Jan 20094:41 pmRNSSecond Price Monitoring Extn
15th Jan 20094:35 pmRNSPrice Monitoring Extension
6th Jan 20099:57 amPRNTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.